FDA OK’s IMDx H1N1 Test

Xconomy Boston — 

IntelligentMDx, a Cambridge, MA-based maker of molecular diagnostic tests, has garnered FDA emergency use authorization for its product for detecting the H1N1 virus, the company announced today. No test has been approved for identifying H1N1, but the emergency use authorization allows the IntelligentMDx diagnostic assay to be used while the flu outbreak is still in emergency status, a state that is set to expire on April 26 of this year, the company said.